Extragonadal germ cell tumors

Extragonadal Germ Cell Tumors click to access explanations in the original CAP template

This is additional protocol for biopsy specimen.

Suggest Expert Consultation before completion of the reporting.

Gross data elements:

data

- Procedure:
- Tumor site:
- Tumor size:
- Patient age:
+ Serological markers:	Not specified Not performed Serum α-fetoprotein (AFP) (specify level): Serum human chorionic gonadotropin (HCG) (specify level):
+ Other clinical findings:	None identified Associated syndromes (Klinefelter, Down, etc.), specify: Associated malignancy (leukemia, MDS, etc.), specify: Other findings:

Microscopic descriptions:

- Tumor histology and immunohistochemical studies:

Ancillary IHC can include SALL4, OCT3/4, CD30, AFP, Glypican-3 and beta-HCG.

- Histologic type (teratoma):
- Histologic type (teratoma):	- Histologic grade (Norris 1976):
- Histologic type (other germ cell tumors):
- Microscopic Coccyx Involvement:
+ Tumor extent (applicable to adult [post-pubertal] extragonadal germ cell tumors):
+ Lymphatic and / or Vascular Invasion:
+ Perineural invasion:
+ Treatment history:
+ Treatment effect:

Surgical margins:

Regional lymph nodes:

- Number of regional lymph nodes examined:
- Number of lymph nodes involved (specify locations):
- Extranodal extension:
- Size of largest metastatic deposit (mm), specify site:
- Size of largest lymph node involved (mm), specify site:

Distant Metastasis: Not applicable Not identified Intrathoracic organ(s) or site(s) (i.e., lymph nodes, lung, etc.) (specify): Liver (specify): Other extrathoracic organ(s) or site(s) (specify): Cannot be determined:

+ Sizes of distant metastasis (cm):
+ Histologic type(s), specify:

Pathologic Stage Classification :

- Children’s Oncology Group Staging (for all GCT):
- Moran and Suster Proposed Clinical Staging (for Mediastinal):

+ Additional pathologic findings: